Nanostructured drug delivery for better management of tuberculosis
With almost 30% of the world population suffering from tuberculosis (TB) including its
resurgence in the developed world, better management of this global threat is highly …
resurgence in the developed world, better management of this global threat is highly …
Inhaled drug treatment for tuberculosis: Past progress and future prospects
AJ Hickey, PG Durham, A Dharmadhikari… - Journal of Controlled …, 2016 - Elsevier
Since the 1990s the rising incidence of multiple drug resistant TB, particularly in the context
of human immunodeficiency virus co-infected patients, has threatened global TB control. At …
of human immunodeficiency virus co-infected patients, has threatened global TB control. At …
Liposomes for drug delivery to the lungs by nebulization
M Zaru, S Mourtas, P Klepetsanis, AM Fadda… - European Journal of …, 2007 - Elsevier
Preparation of drug-loaded freeze-dried (FD) liposomes, designed for delivery to lungs after
rehydration/nebulization was investigated. Rifampicin (RIF) incorporating multilamelar …
rehydration/nebulization was investigated. Rifampicin (RIF) incorporating multilamelar …
Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment
The study investigated aerosolization, pulmonary inhalation, intracellular trafficking potential
in macrophages and pharmacokinetics profiles of rifampicin-oleic acid first-generation …
in macrophages and pharmacokinetics profiles of rifampicin-oleic acid first-generation …
Macrophage-targeted lipid nanoparticle delivery of microRNA-146a to mitigate hemorrhagic shock-induced acute respiratory distress syndrome
The pro-inflammatory response of alveolar macrophages to injurious physical forces during
mechanical ventilation is regulated by the anti-inflammatory microRNA, miR-146a …
mechanical ventilation is regulated by the anti-inflammatory microRNA, miR-146a …
[图书][B] Nanoparticle based drug delivery systems for treatment of infectious diseases
M Salouti, A Ahangari - 2014 - books.google.com
The chemotherapy of infections caused by bacteria that inhabit intracellularly presents a
number of uncommon challenges. Many bacteria have found the way to produce a “silent” …
number of uncommon challenges. Many bacteria have found the way to produce a “silent” …
Nanomedicine as a promising strategy for the theranostics of infectious diseases
H Liu, W Zhong, X Zhang, D Lin, J Wu - Journal of Materials Chemistry …, 2021 - pubs.rsc.org
Infectious diseases caused by bacteria, viruses, and fungi and their global spread pose a
great threat to human health. The 2019 World Health Organization report predicted that …
great threat to human health. The 2019 World Health Organization report predicted that …
Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis
SM Hwang, DD Kim, SJ Chung, CK Shim - Journal of controlled Release, 2008 - Elsevier
Microspheres containing ofloxacin (HMO) with a mean diameter of 2–5 μm were prepared
by the co-spray drying of ofloxacin and the sodium salt of hyaluronic acid (hyaluronan) …
by the co-spray drying of ofloxacin and the sodium salt of hyaluronic acid (hyaluronan) …
Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation
Liposomes were used to encapsulate rifampicin (RIF) as an alternative formulation for
delivery to the respiratory tract. Factors affecting the stability of liposomes containing RIF …
delivery to the respiratory tract. Factors affecting the stability of liposomes containing RIF …
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis
The goal of the work was to evaluate an anti-tubercular strategy based on breathable Solid
Lipid Microparticles (SLM) to target alveolar macrophages and to increase the effectiveness …
Lipid Microparticles (SLM) to target alveolar macrophages and to increase the effectiveness …